FTSE 100’s record run fades as pharma stocks slide on new Trump appointment 

City A.M.

Published

The FTSE 100’s record run was poised to come to an end on Wednesday as pharma stocks slumped on the back of a controversial US regulatory appointment.  The blue-chip index was down 0.3 per cent in mid-morning trading. Drugmakers GSK and Astrazeneca were among the top fallers, at nearly four per cent and two per [...]

Full Article